Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04623047 · ClinicalTrials.gov registry record
Infection Watch Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 10,034
- Enrollment target
NCT04623047: Completed study, sponsored by Duke University.
NCT04623047 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 10,034 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04623047 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 10,034 participants
- Enrollment target
Study Summary
This study will reach out to patients who have undergone diagnostic testing for the following respiratory illnesses from January 1st, 2018 to July 9th, 2023: COVID-19, Influenza, Rhinovirus, and Respiratory Syncytial Virus. This study aims to develop a forecasting model to predict infection onset prior to symptom onset using wearable device data and known symptom onset and test dates.
Primary Outcome
Known symptom onset and test dates will serve to validate the model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,034 participants |
| Start Date | 2023-06-28 |
| Est. Completion | 2024-06-15 |
What the finished NCT04623047 record still lists
NCT04623047 is an observational study that tracks outcomes without assigning an intervention. Its 10,034 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04623047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04623047 about?
NCT04623047 is a clinical study titled "Infection Watch Study". This study will reach out to patients who have undergone diagnostic testing for the following respiratory illnesses from January 1st, 2018 to July 9th, 2023: COVID-19, Influenza, Rhinovirus, and Respiratory Syncytial Virus. This study aims to develop a forecasting model to predict infection onset pr...
What is the current status of trial NCT04623047?
This trial is currently completed. The enrollment target is 10,034 participants. The study started on 2023-06-28. Estimated completion is 2024-06-15.
Who is sponsoring clinical trial NCT04623047?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI